Cediranib is a potent and selective inhibitor of VEGF with antineoplastic activities. It inhibits all three vascular endothelial growth factor receptor (VEGF-1,-2,-3) tyrosine kinases, thereby blocking VEGF-signaling, angiogenesis, and tumor cell growth.

857036-77-2

C29H31FN4O7

566.58

AZD 2171;Recentin;西地尼布马来酸盐;AZD2171;AZD2171 maleate;AZD-2171;Cediranib maleate

DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years